The serum triple screening test (STS) composed of AFP, uE3, and hCG (or β-hCG) measurements during the second trimester is one of the most commonly used prenatal screening tools for DS, although the sensitivity and specificity of this test are unsatisfactory23, 24. This evidence concerns the gene AFP and Dravet syndrome.